share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dhaliwal Jatinder

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dhaliwal Jatinder

Virpax制药 | 4：持股变动声明-董事 Dhaliwal Jatinder
美股sec公告 ·  07/09 16:06
Moomoo AI 已提取核心信息
In a recent transaction, Jatinder Dhaliwal, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on July 5, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The number of shares held by Dhaliwal after the transaction is also undisclosed. This information is critical for investors monitoring insider activity and gauging market sentiment towards Virpax Pharmaceuticals.
In a recent transaction, Jatinder Dhaliwal, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on July 5, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The number of shares held by Dhaliwal after the transaction is also undisclosed. This information is critical for investors monitoring insider activity and gauging market sentiment towards Virpax Pharmaceuticals.
最近，维尔帕克斯药品公司（VRPX）的相关人员贾廷德·达利瓦尔（Jatinder Dhaliwal）在2024年7月5日进行了股票交易。交易的具体细节，包括涉及的股份数量、股份性质、交易价格以及股份的总价值都尚未披露。达利瓦尔交易后持有的股份数量也未公开。这些信息对于监控内幕交易及衡量市场对维尔帕克斯药品公司看法的投资者来说至关重要。
最近，维尔帕克斯药品公司（VRPX）的相关人员贾廷德·达利瓦尔（Jatinder Dhaliwal）在2024年7月5日进行了股票交易。交易的具体细节，包括涉及的股份数量、股份性质、交易价格以及股份的总价值都尚未披露。达利瓦尔交易后持有的股份数量也未公开。这些信息对于监控内幕交易及衡量市场对维尔帕克斯药品公司看法的投资者来说至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息